|
John Sedivy is recognized for his efforts in mammalian cell genetics, having developed and pioneered methods for gene targeting of somatic cells. In 1995 his laboratory isolated the first viable gene knockout of the Myc oncogene, and in 1997 the first homozygous gene knockout in a normal human cell. Part of his research program continues to investigate cell cycle regulation in cancer. Since 1998 his research has also focused on the biology of human aging at the cellular level. These projects currently investigate how telomere shortening as well as telomere-independent stresses cause cellular senescence.
Overview | Research | Grants/Awards | Teaching | Publications
Professor John Sedivy joined the Brown Faculty in 1996 and is a member and Chair of the Department of Molecular Biology, Cell Biology and Biochemistry. He obtained his PhD from Harvard in 1985, and subsequently trained with the Nobel Laureate Philip Sharp at the MIT Center for Cancer Research. He started his independent research career at Yale University in 1988.
|
![]() JOHN SEDIVY, PHD http://research.brown.edu/myresearch/John_Sedivy On The Web: By knocking out gene p21, research team temporarily thwarts human cells' aging process Findings about cell division yield new target for cancer drug Research on biology of aging puts Brown on the map (GSJ of June 25, 2004) Cellular Senescence in Aging Primates - reprint Cellular Senescence in Aging Primates - abstract Brown collaborators:Are you John Sedivy? Click here to edit your research profile. |